Picture EBD Group BIO-Europe 2026 Köln Cologne to 31 Jul 650x100px

Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Merck KGaA to Acquire Bio-Techne for $11.3b (€9.9b) (2026-06-25)
> Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) > Proposed acquisition expected to be immediately accretive to sales growth and EBITDA pre margin post-closing, and EPS pre accretive by year 3 after ...
Tecan Integrates Nvidia’s Agentic AI into Lab Platform (2026-06-24)
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging NVIDIA BioNeMo Agent Toolkit. The NVIDIA BioNeMo Agent Tool...
Merck Announces Healthcare Leadership Changes (2026-06-24)
Miguel Fernández Alcalde has been appointed Head of Global Commercial Strategy. Monia Vial is appointed President of EMD Serono Merck, a leading science and technology company which operates its Healthcare business sector as EMD Serono in the U.S. and Canada,...
RQ Biotechnology Closes $115m (£85.5m) Series A Financing (2026-06-24)
> Financing led by Frazier Life Sciences with participation from new investors EQT Life Sciences, Forbion, Monograph, Wellington Management and founding investor LifeArc Ventures > Proceeds support clinical development of lead programme RQB01 designed to provide...
Nvidia Announces BioNeMo Agent Toolkit at BIO 2026 (2026-06-23)
News Summary: > Industry and research leaders including Dassault Systèmes, Databricks, Lilly, Schrödinger, Snowflake, the UW Medicine Institute for Protein Design and dozens others are adopting, and Anthropic and OpenAI are integrating, NVIDIA BioNeMo Agent To...
Coulter Partners Places Vincent Metzler as CEO of Cellcolabs (2026-06-23)
Coulter Partners successfully led a search for Cellcolabs and is pleased to announce the placement of Vincent Metzler, Ph.D., as Chief Executive Officer (CEO). Cellcolabs is a Swedish biotechnology company specializing in the large-scale, industrial production o...
Merck Partners with Versant Ventures to Launch Saturnus Bio (2026-06-23)
> Saturnus Bio is a next-generation precision cardiology company that utilizes targeted gene modulation to address rare mono-genetic cardiomyopathies with significant unmet need. > The collaboration will augment Merck’s efforts to pursue precision medicine-def...
Graph Therapeutics Raises $5m Investment Led by Daphni (2026-06-22)
Graph Therapeutics (“Graph”) announces that Daphni, the Paris-based venture capital firm, has joined Graph’s investor syndicate to accelerate its internal pipeline. Daphni invests alongside continued participation from existing investors SquareOne, Merantix C...
Europe Unveils a Record 35 New Nvidia AI Supercomputers (2026-06-22)
Expanded Access to Next-Generation NVIDIA AI Infrastructure Equips Millions of Researchers to Advance AI HPC and Scientific Discovery News Summary: > Barcelona Supercomputing Center’s EuroHPC AI Factory, BavariaAI’s Blue Swan, IT4LIA, HLRS’s HammerHAI...
Kos Biotechnology Partners: First Fund Reaches $123m (2026-06-13)
Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma ecosystem with Europe, today announced the third closing of its inaugural global life sciences fund, bringing total capital commitments to $123M (€106M). Followin...

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

Picture Berlin Partner Voices Surjo Soekadar 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]